Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Relevance of a Web-mediated Follow up in Patients Having a Lymphoma With a High Risk of Relapse in Complete or Partial Response

NCT03154710 is registered in ClinicalTrials.gov with Weprom as lead sponsor.

NCT NCT03154710
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03154710 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Relevance of a Web-mediated Follow up in Patients Having a Lymphoma With a High Risk of Relapse in Complete or Partial Response
Lead sponsor
Weprom
Phase
Not applicable
Overall status
Terminated
Start date
July 12, 2017
Completion date
March 12, 2021
Enrollment
52 (actual)
Sites
15

Conditions

As the registry lists them; a condition with its own page is linked.

lymphoma, hodgkin, lymphoma, large b-cell, diffuse, lymphoma, t-cell